First-in-Human Study: Immune-Engineered Cell Therapy for Type 1 Diabetes
Researchers have initiated the first-in-human clinical trial of an immune-engineered cell therapy designed to treat type 1 diabetes. By utilizing encapsulated, insulin-producing cells protected from immune system rejection, this approach ... Read More